Anemia of Inflammation vs Iron Deficiency Anemia: New Diagnostic Tools and Therapies Please like and subscribe if you enjoyed this video :-) Abstract This paper provides a clear, up-to-date overview of how anemia of inflammation (AI) and iron deficiency anemia (IDA) differ,
Cardiology
How AI Achieves 94% Accuracy in Early Disease Detection: New Research Findings
Efficacy of Telemedicine in Improving Healthcare Access Across Specialties
Efficacy of Telemedicine in Improving Healthcare Access Across Specialties Please like and subscribe if you enjoyed this video :-) Abstract This paper examines the effectiveness of telemedicine in improving access to healthcare across various medical specialties. By analyzing recent evidence from diverse
SGLT2 Inhibitors in Heart Failure: New Evidence Changes Treatment Protocols
Heart Ablation Success Rate: New Study Shows 87% Long-Term Freedom from AF
Heart Ablation Success Rate: New Study Shows 87% Long-Term Freedom from AF Introduction Recent advancements in heart ablation have led to remarkable improvements in success rates, particularly with the use of AI-guided procedures. Studies show that AI-assisted ablation achieves an 88% success rate in keeping patients free from atrial
Breakthrough Heart Treatments of 2025- A New Era in Cardiology
IRON DEFICIENCY’S IMPACT ON NEW-ONSET CHRONIC HEART FAILURE OUTCOME: DANISH HEART FAILURE REGISTRY INSIGHTS
Dofetilide In Structural Heart Disease
Dofetilide In Structural Heart Disease Overview Dofetilide, a class III antiarrhythmic drug, is approved for managing atrial fibrillation and atrial flutter, but it has also been used off-label to treat premature ventricular complexes (PVCs) and ventricular tachycardias (VTs). This study aimed to assess the efficacy and safety of dofetilide for
Mortality In Cancer Patients: Cardio Mortality Meta-Analysis
Mortality In Cancer Patients: Cardio Mortality Meta-Analysis Overview Cardiovascular disease (CVD) is a significant cause of non-cancer-related death among cancer survivors, although the level of risk varies depending on the type of cancer. This study aims to review and synthesize existing evidence regarding patterns and the extent of CVD mortality risk
Stellate Ganglion Block Success In Recurrent Ventricular Arrhythmias
Stellate Ganglion Block Success In Recurrent Ventricular Arrhythmias Overview One potential treatment for refractory ventricular arrhythmias is a stellate ganglion block (SGB). This study analyzed the effectiveness of SGB based on patient and arrhythmia characteristics, as well as predictors of success. Conducted across multiple centers in the Czech Republic and the United
